Alector, Inc. (ALEC) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 13.86M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $13.86M | (m) | (m) |
| 2026-03-31 | (m) | $18.42M | (m) | (m) |
| 2025-12-31 | (m) | $21.05M | (m) | (m) |
| 2025-09-30 | (m) | $69.05M | (m) | (m) |
| 2025-06-30 | (m) | $81.13M | (m) | (m) |
| 2025-03-31 | (m) | $88.34M | (m) | (m) |
| 2024-12-31 | (m) | $100.56M | (m) | (m) |
| 2024-09-30 | (m) | $61.51M | (m) | (m) |
| 2024-06-30 | (m) | $55.27M | (m) | (m) |
| 2024-03-31 | (m) | $96.41M | (m) | (m) |
| 2023-12-31 | (m) | $97.06M | (m) | (m) |
| 2023-09-30 | (m) | $96.31M | (m) | (m) |
| 2023-06-30 | (m) | $102.06M | (m) | (m) |
| 2023-03-31 | (m) | $125.69M | (m) | (m) |
| 2022-12-31 | (m) | $133.62M | (m) | (m) |
| 2022-09-30 | (m) | $133.17M | (m) | (m) |
| 2022-06-30 | (m) | $300.73M | (m) | (m) |
| 2022-03-31 | (m) | $227.45M | (m) | (m) |
| 2021-12-31 | (m) | $207.09M | (m) | (m) |
| 2021-09-30 | (m) | $197.94M | (m) | (m) |
| 2021-06-30 | (m) | $21.43M | (m) | (m) |
| 2021-03-31 | (m) | $18.04M | (m) | (m) |
| 2020-12-31 | (m) | $21.10M | (m) | (m) |
| 2020-09-30 | (m) | $22.25M | (m) | (m) |
| 2020-06-30 | (m) | $19.04M | (m) | (m) |
| 2020-03-31 | (m) | $22.79M | (m) | (m) |
| 2019-12-31 | (m) | $21.22M | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $27.51M | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $2.87M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |